Transplant International最新文献

筛选
英文 中文
Burnout Among Physicians of Specialties Dedicated to Liver Transplantation. 肝移植专业医师的职业倦怠。
IF 2.7 3区 医学
Transplant International Pub Date : 2024-11-14 eCollection Date: 2024-01-01 DOI: 10.3389/ti.2024.13738
Gloria Sanchez-Antolín, Gerardo Blanco-Fernández, Isabel Campos-Varela, Patricia Ruiz, José M Álamo, Alejandra Otero, Sonia Pascual, Laura Lladó
{"title":"Burnout Among Physicians of Specialties Dedicated to Liver Transplantation.","authors":"Gloria Sanchez-Antolín, Gerardo Blanco-Fernández, Isabel Campos-Varela, Patricia Ruiz, José M Álamo, Alejandra Otero, Sonia Pascual, Laura Lladó","doi":"10.3389/ti.2024.13738","DOIUrl":"10.3389/ti.2024.13738","url":null,"abstract":"<p><p>Burnout is increasingly relevant among healthcare professionals. The aim of this study is to describe the prevalence of burnout and other parameters of professional satisfaction among different specialists dedicated to Liver Transplantation (LT) in transplant teams. A working group from the Spanish Society of LT designed a survey with 39 questions evaluating the prevalence of parameters related to professional satisfaction, including burnout. It was distributed among 496 specialists dedicated to liver transplantation in Spanish transplant teams. Responders included surgeons (49%), hepatologists (27%), anesthesiologists (16%), intensivists (4%), and other specialties (4%). Among responders, 78% reported some degree of burnout. Moreover, 46% of responders did not see themselves working in transplantation in 5 years. The rates of burnout and dissatisfaction among anesthesiologists and surgeons were higher than other specialists. The highest levels of dissatisfaction were in economic remuneration and work-life balance. Being younger than 60 years old and non-head of department showed to be risk factors of burnout. In conclusion, the prevalence of burnout among LT physicians in Spain was notably high. Among the various specialties, anesthesiologists and surgeons exhibited the highest dissatisfaction rates. The results of this work may be of interest to healthcare management and planning.</p>","PeriodicalId":23343,"journal":{"name":"Transplant International","volume":"37 ","pages":"13738"},"PeriodicalIF":2.7,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11602281/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142751831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Normothermic Machine Perfusion Reconstitutes Porcine Kidney Tissue Metabolism But Induces an Inflammatory Response, Which Is Reduced by Complement C5 Inhibition. 常温机器灌注可重建猪肾组织代谢,但会诱发炎症反应,而抑制补体 C5 可减轻炎症反应。
IF 2.7 3区 医学
Transplant International Pub Date : 2024-11-13 eCollection Date: 2024-01-01 DOI: 10.3389/ti.2024.13348
Eline de Boer, Marina Sokolova, Neeltina M Jager, Camilla Schjalm, Marc G Weiss, Olav M Liavåg, Hanno Maassen, Harry van Goor, Ebbe Billmann Thorgersen, Kristin Pettersen, Dorte Christiansen, Judith Krey Ludviksen, Bente Jespersen, Tom E Mollnes, Henri G D Leuvenink, Søren E Pischke
{"title":"Normothermic Machine Perfusion Reconstitutes Porcine Kidney Tissue Metabolism But Induces an Inflammatory Response, Which Is Reduced by Complement C5 Inhibition.","authors":"Eline de Boer, Marina Sokolova, Neeltina M Jager, Camilla Schjalm, Marc G Weiss, Olav M Liavåg, Hanno Maassen, Harry van Goor, Ebbe Billmann Thorgersen, Kristin Pettersen, Dorte Christiansen, Judith Krey Ludviksen, Bente Jespersen, Tom E Mollnes, Henri G D Leuvenink, Søren E Pischke","doi":"10.3389/ti.2024.13348","DOIUrl":"10.3389/ti.2024.13348","url":null,"abstract":"<p><p>Normothermic machine perfusion (NMP) is a clinical strategy to reduce renal ischemia-reperfusion injury (IRI). Optimal NMP should restore metabolism and minimize IRI induced inflammatory responses. Microdialysis was used to evaluate renal metabolism. This study aimed to assess the effect of complement inhibition on NMP induced inflammatory responses. Twenty-two pig kidneys underwent 18 h of static cold storage (SCS) followed by 4 h of NMP using a closed-circuit system. Kidneys were randomized to receive a C5-inhibitor or placebo during SCS and NMP. Perfusion resulted in rapidly stabilized renal flow, low renal resistance, and urine production. During SCS, tissue microdialysate levels of glucose and pyruvate decreased significantly, whereas glycerol increased (p < 0.001). In the first hour of NMP, glucose and pyruvate increased while glycerol decreased (p < 0.001). After 4 h, all metabolites had returned to baseline. Inflammatory markers C3a, soluble C5b-9, TNF, IL-6, IL-1β, IL-8, and IL-10 increased significantly during NMP in perfusate and kidney tissue. C5-inhibition significantly decreased perfusate and urine soluble C5b-9 (<i>p</i> < 0.001; <i>p</i> = 0.002, respectively), and tissue IL-1β (<i>p</i> = 0.049), but did not alter other inflammatory markers. Microdialysis can accurately monitor the effect of NMP on renal metabolism. Closed-circuit NMP induces inflammation, which appeared partly complement-mediated. Targeting additional immune inhibitors should be the next step.</p>","PeriodicalId":23343,"journal":{"name":"Transplant International","volume":"37 ","pages":"13348"},"PeriodicalIF":2.7,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11598510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142740567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angiotensin II Type-1 Receptor Antibody in Solid Organ Transplantation - Is It Time to Test? 血管紧张素 II-1 型受体抗体在实体器官移植中的应用--是时候进行测试了吗?
IF 2.7 3区 医学
Transplant International Pub Date : 2024-11-13 eCollection Date: 2024-01-01 DOI: 10.3389/ti.2024.13280
Paul James Patrick Martin, Michelle Willicombe, Candice Roufosse
{"title":"Angiotensin II Type-1 Receptor Antibody in Solid Organ Transplantation - Is It Time to Test?","authors":"Paul James Patrick Martin, Michelle Willicombe, Candice Roufosse","doi":"10.3389/ti.2024.13280","DOIUrl":"10.3389/ti.2024.13280","url":null,"abstract":"<p><p>Angiotensin II type-1 receptor antibody (AT1R-Ab) has been mooted as a potential effector of both acute and chronic antibody mediated rejection (AMR). A growing body of literature on the topic is now coming under scrutiny in the context of the evolving Banff AMR diagnostic classification system and refinement of recommendations for histocompatibility testing by the Sensitization in Transplantation Assessment of Risk (STAR) workgroup. This mini-review discusses the latest understanding of pathophysiological mechanisms, clinical evidence for the pathogenicity of AT1R-Ab, and methods of laboratory testing.</p>","PeriodicalId":23343,"journal":{"name":"Transplant International","volume":"37 ","pages":"13280"},"PeriodicalIF":2.7,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11598415/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142740646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allorecognition Unveiled: Integrating Recent Breakthroughs Into the Current Paradigm. Allorecognition Unveiled:将最新突破融入当前范式。
IF 2.7 3区 医学
Transplant International Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.3389/ti.2024.13523
Xavier Charmetant, Gavin J Pettigrew, Olivier Thaunat
{"title":"Allorecognition Unveiled: Integrating Recent Breakthroughs Into the Current Paradigm.","authors":"Xavier Charmetant, Gavin J Pettigrew, Olivier Thaunat","doi":"10.3389/ti.2024.13523","DOIUrl":"10.3389/ti.2024.13523","url":null,"abstract":"<p><p>In transplantation, genetic differences between donor and recipient trigger immune responses that cause graft rejection. Allorecognition, the process by which the immune system discriminates allogeneic grafts, targets major histocompatibility complex (MHC) and minor histocompatibility antigens. Historically, it was believed that allorecognition was solely mediated by the recipient's adaptive immune system recognizing donor-specific alloantigens. However, recent research has shown significant roles for innate immune components, such as lymphoid and myeloid cells, which are sometimes triggered by the mere absence of a self-protein in the graft. This review integrates recent breakthroughs into the current allorecognition paradigm based on the well-established direct and indirect pathways, emphasizing the semi-direct pathway where recipient antigen-presenting cells (APCs) acquire donor MHC molecules, and the inverted direct pathway where donor CD4<sup>+</sup> T cells within the graft activate recipient B cells to produce donor-specific antibodies (DSAs). The review also explores the role of natural killer (NK) cells in both promoting and inhibiting graft rejection, highlighting their dual role in innate allorecognition. Additionally, it discusses the emerging understanding of myeloid cell-mediated allorecognition and its implications for initiating adaptive immune responses. These insights aim to provide a more comprehensive understanding of allorecognition, potentially leading to improved transplant outcomes.</p>","PeriodicalId":23343,"journal":{"name":"Transplant International","volume":"37 ","pages":"13523"},"PeriodicalIF":2.7,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11586167/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142716423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of the EVLP on the lung microbiome and its inflammatory reaction. EVLP 对肺部微生物群及其炎症反应的影响。
IF 2.7 3区 医学
Transplant International Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.3389/ti.2024.12979
Leandro Grando, Marc Boada, Rosa Faner, Susana Gómez-Ollés, Victoria Ruiz, Marc Bohils, Joaquim Albiol, Ramses Marrero, Laia Rosell, Ivan Salinas, Daniel Ruiz, Ángel Ruiz, Camino Rodríguez-Villar, Anna Ureña, David Paredes-Zapata, Ángela Guirao, Gerard Sánchez-Etayo, Laureano Molins, Néstor Quiroga, Aroa Gómez-Brey, Xavier Michavila, Alberto Sandiumenge, Àlvar Agustí, Ricard Ramos, Irene Bello
{"title":"The impact of the EVLP on the lung microbiome and its inflammatory reaction.","authors":"Leandro Grando, Marc Boada, Rosa Faner, Susana Gómez-Ollés, Victoria Ruiz, Marc Bohils, Joaquim Albiol, Ramses Marrero, Laia Rosell, Ivan Salinas, Daniel Ruiz, Ángel Ruiz, Camino Rodríguez-Villar, Anna Ureña, David Paredes-Zapata, Ángela Guirao, Gerard Sánchez-Etayo, Laureano Molins, Néstor Quiroga, Aroa Gómez-Brey, Xavier Michavila, Alberto Sandiumenge, Àlvar Agustí, Ricard Ramos, Irene Bello","doi":"10.3389/ti.2024.12979","DOIUrl":"10.3389/ti.2024.12979","url":null,"abstract":"<p><p>The pulmonary microbiome has emerged as a significant factor in respiratory health and diseases. Despite the sterile conditions maintained during <i>ex vivo</i> lung perfusion (EVLP), the use of antibiotics in the perfuse liquid can lead to dynamic changes in the lung microbiome. Here, we present the design of a study that aims to investigate the hypothesis that EVLP alters the lung microbiome and induces tissue inflammation. This pilot, prospective, controlled study will be conducted in two Spanish donor centers and will include seven organ donors after brain death or after controlled cardiac death. After standardized retrieval, the left lung will be preserved in cold storage and the right lung will be perfused with EVLP. Samples from bronchoalveolar lavage, perfusion and preservation solutions, and lung biopsies will be collected from both lungs and changes in lung microbiome and inflammatory response will be compared.</p>","PeriodicalId":23343,"journal":{"name":"Transplant International","volume":"37 ","pages":"12979"},"PeriodicalIF":2.7,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587763/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142716424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjusted Donor Age: A Clinical Score to Support Organ Acceptance Decisions in Deceased-Donor Kidney Transplantation. 调整供体年龄:支持已故供体肾移植中器官接受决定的临床评分。
IF 2.7 3区 医学
Transplant International Pub Date : 2024-11-07 eCollection Date: 2024-01-01 DOI: 10.3389/ti.2024.13477
Rupert Bright, Christoph F Mahler, Anamika Adwaney, Dhriti Dosani, Emma Morganti, Felix Friedl, Christian Nusshag, Claudius Speer, Louise Benning, Daniel Göth, Matthias Schaier, Claudia Sommerer, Markus Mieth, Arianeb Mehrabi, Martin Zeier, Christian Morath, Frank J M F Dor, Florian Kälble, Damien Ashby
{"title":"Adjusted Donor Age: A Clinical Score to Support Organ Acceptance Decisions in Deceased-Donor Kidney Transplantation.","authors":"Rupert Bright, Christoph F Mahler, Anamika Adwaney, Dhriti Dosani, Emma Morganti, Felix Friedl, Christian Nusshag, Claudius Speer, Louise Benning, Daniel Göth, Matthias Schaier, Claudia Sommerer, Markus Mieth, Arianeb Mehrabi, Martin Zeier, Christian Morath, Frank J M F Dor, Florian Kälble, Damien Ashby","doi":"10.3389/ti.2024.13477","DOIUrl":"10.3389/ti.2024.13477","url":null,"abstract":"<p><p>As transplant programmes have evolved to allow a wider donor pool, organ acceptance decisions have become increasingly complex and lack transparency and equality. Clinical scoring tools exist but there is limited consensus on their use. From a prospective observation of consecutive deceased-donor kidney offers in a large urban transplant centre, a simple score was developed based on donor age and other risk characteristics, excluding ischemia time and graft histology. The score was validated in subsequent cohorts of consecutive offers in the United Kingdom and Germany. In the development cohort of 389 kidney offers, 110 (28%) were transplanted and 175 (45%) declined. Nine risk factors were incorporated into a score based on age, but adjusted for the number of risk factors present, making an \"adjusted donor age,\" with offers separated into equal quintiles by decade. The score was validated in a UK cohort of 380 subsequent offers, and a German cohort of 431 offers. In both cohorts adjusted donor age discriminated between favourable and poor post-transplant outcomes (C-statistic 0.77 in the United Kingdom, 95% CI 0.65-0.88, and 0.71 in Germany, 95% CI 0.64-0.77). Adjusted donor age is a simple score quantifying deceased donor kidney quality, which is consistent with current practice and predicts post-transplant outcome.</p>","PeriodicalId":23343,"journal":{"name":"Transplant International","volume":"37 ","pages":"13477"},"PeriodicalIF":2.7,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11578704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142688991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vascular Reconstruction of Multiple Renal Arteries-A Risk Factor for Transplant Renal Artery Stenosis: Insight From a Matched Case-Control Study. 多肾动脉血管重建--移植肾动脉狭窄的危险因素:一项匹配病例对照研究的启示。
IF 2.7 3区 医学
Transplant International Pub Date : 2024-11-07 eCollection Date: 2024-01-01 DOI: 10.3389/ti.2024.13298
Devprakash Choudhary, Rajesh Vijayvergiya, Kamal Kishore, Vanji Nathan Subramani, Mohan Banoth, Sai Praneeth Reddy Perugu, Milind Mandwar, Bharat Bamaniya, Arun Panjathia, Parul Gupta, Shiva Kumar S Patil, Jasmine Sethi, Ujjwal Gorsi, Sarbpreet Singh, Deepesh Kenwar, Ashish Sharma
{"title":"Vascular Reconstruction of Multiple Renal Arteries-A Risk Factor for Transplant Renal Artery Stenosis: Insight From a Matched Case-Control Study.","authors":"Devprakash Choudhary, Rajesh Vijayvergiya, Kamal Kishore, Vanji Nathan Subramani, Mohan Banoth, Sai Praneeth Reddy Perugu, Milind Mandwar, Bharat Bamaniya, Arun Panjathia, Parul Gupta, Shiva Kumar S Patil, Jasmine Sethi, Ujjwal Gorsi, Sarbpreet Singh, Deepesh Kenwar, Ashish Sharma","doi":"10.3389/ti.2024.13298","DOIUrl":"10.3389/ti.2024.13298","url":null,"abstract":"<p><p>Transplant Renal Artery Stenosis (TRAS) is the leading vascular complication following kidney transplantation (KT), causing premature allograft loss and increased post-KT mortality. While risk factors for TRAS, such as prolonged cold ischemia time and delayed graft function, are well-documented in deceased donor-KT, the risk factors remain less clearly defined in living donor-KT. This matched case-control study, conducted at a leading national transplant center predominantly performing living donor-KT, evaluated risk factors and long-term outcomes of clinical TRAS (cTRAS). cTRAS cases diagnosed from January 2009 to December 2022 were matched with four control kidney transplant recipients (KTRs) in a study powered to assess whether <i>ex-vivo</i> arterial vascular reconstruction of multiple renal arteries (VR-MRA) increases the risk of cTRAS. Among 2,454 KTs, 28 KTRs (1.14%) were diagnosed with cTRAS around 3.62 ± 1.04 months post-KT, with renal allograft dysfunction (92.86%) as the most common presenting feature. Notably, 27 cTRAS cases were successfully treated with endovascular intervention, yielding favorable outcomes over a 6-180 months follow-up period. The study identified <i>ex-vivo</i> VR-MRA as an independent risk factor for cTRAS (P < 0.001). cTRAS cases receiving timely treatment exhibited long-term outcomes in graft and patient survival similar to control KTRs. Early screening and timely intervention for cTRAS post-KT may improve graft and patient outcomes.</p>","PeriodicalId":23343,"journal":{"name":"Transplant International","volume":"37 ","pages":"13298"},"PeriodicalIF":2.7,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11580035/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142688992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum: Glycolysis Changes in Alloreactive Memory B Cells in Highly Sensitized Kidney Transplant Recipients Undergoing Desensitization Therapy. 更正:接受脱敏疗法的高度敏感肾移植受者异体反应记忆 B 细胞的糖酵解变化。
IF 2.7 3区 医学
Transplant International Pub Date : 2024-11-04 eCollection Date: 2024-01-01 DOI: 10.3389/ti.2024.13876
Johan Noble, Lara Cabezas, Aurelie Truffot, Lucile Dumolard, Thomas Jouve, Paolo Malvezzi, Lionel Rostaing, Céline Dard, Philippe Saas, Paolo Cravedi, Zuzana Macek-Jilkova
{"title":"Corrigendum: Glycolysis Changes in Alloreactive Memory B Cells in Highly Sensitized Kidney Transplant Recipients Undergoing Desensitization Therapy.","authors":"Johan Noble, Lara Cabezas, Aurelie Truffot, Lucile Dumolard, Thomas Jouve, Paolo Malvezzi, Lionel Rostaing, Céline Dard, Philippe Saas, Paolo Cravedi, Zuzana Macek-Jilkova","doi":"10.3389/ti.2024.13876","DOIUrl":"10.3389/ti.2024.13876","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3389/ti.2024.13029.].</p>","PeriodicalId":23343,"journal":{"name":"Transplant International","volume":"37 ","pages":"13876"},"PeriodicalIF":2.7,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572526/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Activation of the Innate Immune System in Brain-Dead Donors Can Be Reduced by Luminal Intestinal Preservation During Organ Procurement Surgery - A Porcine Model. 在器官获取手术中保留腔肠可减少脑死亡捐献者先天性免疫系统的激活--猪模型。
IF 2.7 3区 医学
Transplant International Pub Date : 2024-10-31 eCollection Date: 2024-01-01 DOI: 10.3389/ti.2024.13569
Marc Gjern Weiss, Anne Marye de Jong, Helene Seegert, Niels Moeslund, Hanno Maassen, Camilla Schjalm, Eline de Boer, Henri Leuvenink, Tom Eirik Mollnes, Marco Eijken, Anna Krarup Keller, Gerard Dijkstra, Bente Jespersen, Søren Erik Pischke
{"title":"Activation of the Innate Immune System in Brain-Dead Donors Can Be Reduced by Luminal Intestinal Preservation During Organ Procurement Surgery - A Porcine Model.","authors":"Marc Gjern Weiss, Anne Marye de Jong, Helene Seegert, Niels Moeslund, Hanno Maassen, Camilla Schjalm, Eline de Boer, Henri Leuvenink, Tom Eirik Mollnes, Marco Eijken, Anna Krarup Keller, Gerard Dijkstra, Bente Jespersen, Søren Erik Pischke","doi":"10.3389/ti.2024.13569","DOIUrl":"10.3389/ti.2024.13569","url":null,"abstract":"<p><p>Organs obtained from brain dead donors can have suboptimal outcomes. Activation of the innate immune system and translocation of intestinal bacteria could be causative. Thirty two pigs were assigned to control, brain death (BD), BD + luminal intestinal polyethylene glycol (PEG), and BD + luminal intestinal University of Wisconsin solution (UW) groups. Animals were observed for 360 min after BD before organ retrieval. 2,000 mL luminal intestinal preservation solution was instilled into the duodenum at the start of organ procurement. Repeated measurements of plasma C3a, Terminal Complement Complex (TCC), IL-8, TNF, and lipopolysaccharide binding protein were analysed by immunoassays. C3a was significantly higher in the BD groups compared to controls at 480 min after brain death. TCC was significantly higher in BD and BD + UW, but not BD + PEG, compared to controls at 480 min. TNF was significantly higher in the BD group compared to all other groups at 480 min. LPS binding protein increased following BD in all groups except BD + PEG, which at 480 min was significantly lower compared with all other groups. Brain death induced innate immune system activation was decreased by luminal preservation using PEG during organ procurement, possibly due to reduced bacterial translocation.</p>","PeriodicalId":23343,"journal":{"name":"Transplant International","volume":"37 ","pages":"13569"},"PeriodicalIF":2.7,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11560447/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142636073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver Transplantation for Intrahepatic Cholangiocarcinoma After Chemotherapy and Radioembolization: An Intention-To-Treat Study. 化疗和放射栓塞后肝内胆管癌的肝移植:意向治疗研究
IF 2.7 3区 医学
Transplant International Pub Date : 2024-10-31 eCollection Date: 2024-01-01 DOI: 10.3389/ti.2024.13641
Marianna Maspero, Carlo Sposito, Marco A Bongini, Tommaso Cascella, Maria Flores, Marco Maccauro, Carlo Chiesa, Monica Niger, Filippo Pietrantonio, Giuseppe Leoncini, Valentina Bellia, Sherrie Bhoori, Vincenzo Mazzaferro
{"title":"Liver Transplantation for Intrahepatic Cholangiocarcinoma After Chemotherapy and Radioembolization: An Intention-To-Treat Study.","authors":"Marianna Maspero, Carlo Sposito, Marco A Bongini, Tommaso Cascella, Maria Flores, Marco Maccauro, Carlo Chiesa, Monica Niger, Filippo Pietrantonio, Giuseppe Leoncini, Valentina Bellia, Sherrie Bhoori, Vincenzo Mazzaferro","doi":"10.3389/ti.2024.13641","DOIUrl":"10.3389/ti.2024.13641","url":null,"abstract":"<p><p>Liver transplantation (LT) is a potentially curative experimental treatment for unresectable intrahepatic cholangiocarcinoma (iCC). Pre-transplant downstaging may help defining tumor aggressiveness and drive patient selection. We report the preliminary results of LT for liver-limited unresectable iCC after sequential downstaging with systemic chemotherapy and radioembolization (SYS-TARE). In case of sustained disease stability after SYS-TARE, patients underwent surgical nodal sampling and, if negative, were listed for LT. In this study, 13 patients with unresectable iCC underwent downstaging with SYS-TARE. The median age was 70 years and 77% were female. All had single bulky lesions at diagnosis. After SYS-TARE, 9 (69%) dropped out: 3 due to progressive disease after TARE with no response to second-line, 4 due to extrahepatic disease development and 2 due to positive nodal disease at pre-listing abdominal exploration. The median OS after dropout was 11.5 months. Four (31%) were successfully listed and transplanted. At pathology, viable tumor ranged from 30% to less than 5%. All four patients are alive and disease-free at 73, 40, 12, and 8 months from LT. LT for unresectable iCC after downstaging with SYS-TARE appears to select suitable patients for LT, achieving optimal oncological outcomes in case of response to therapy and no lymphnodal spread.</p>","PeriodicalId":23343,"journal":{"name":"Transplant International","volume":"37 ","pages":"13641"},"PeriodicalIF":2.7,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11560448/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142636080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信